RCE recce pharmaceuticals ltd

Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-2

  1. 5,496 Posts.
    lightbulb Created with Sketch. 707
    Only read top lines but Yess yes yes lol. Great looking and have been desperately looking forward to

    Highlights:• Broad spectrum antibiotic activity on bacterial Burn Wound infections withvisible infection reduction <24 hours on all patients to date• All infections cleared within 5 days (acute) or 7 days (chronic); clinicians reducing treatment windows per protocol/positive patient indications• Burn wound infections consisted of Gram-positive and Gram-negative bacteria, including multi-drug resistant and ‘biofilm’ categorised forms• Update in-line with reaching clinical trial end-points; patient recruitment ongoing
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
-0.025(5.62%)
Mkt cap ! $121.4M
Open High Low Value Volume
44.0¢ 44.0¢ 41.5¢ $45.92K 107.5K

Buyers (Bids)

No. Vol. Price($)
1 120 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 1000 1
View Market Depth
Last trade - 15.59pm 28/07/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.